Pathstone Family Office, LLC Macrogenics Inc Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
133Shares Held
53MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$15.7 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$9.95 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$8.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$6.99 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.14 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $97.1M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...